Akero Therapeutics, Inc. (AKRO)
$54.65+0.00%Close
BUYBULL · day 38
Key stats
- Market cap
- $4.5B
- Beta
- -0.40
- P/E (TTM)
- -19.87
- 1W
- +0.29%
- 1M
- +1.13%
- vs SPY 1W
- -0.13%
- vs SPY 1M
- -0.93%
Industry peers
FMP comparable companies · ranked by market cap
- KYMRSELLKymera Therapeutics, Inc.$9.2BBEARQ 25$112.08-0.28%
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- PRAXSELLPraxis Precision Medicines, Inc.$7.0BCRISISQ 11$251.38-3.26%
- ACLXArcellx, Inc.$6.7B$115.07
- CNTACentessa Pharmaceuticals plc$6.3B$40.50
- IMVTSELLImmunovant, Inc.$6.1BCRISISQ 25$29.48-3.25%
- ACADSELLAcadia Pharmaceuticals Inc.$3.3BCRISISQ 18$19.41-1.87%
- VKTXSELLViking Therapeutics, Inc.$3.3BCRISISQ 22$28.34-0.60%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- NAMSSELLNewAmsterdam Pharma Company N.V.$2.5BCRISISQ 25$21.25-1.53%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 19
- VALUE
- 8
- GROWTH
- 47
- GARP
- 6
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-13.1%
REV YoY-
ROE-21.8%
EPS YoY-
ROA-22.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-19.87
P/E FWD-
SECTOR PE20.54
INDUSTRY PE14.03
P/B4.68
P/FCF-
EV/EBITDA-19.71
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E0.12
ALTMAN Z-
CURR RATIO15.83
ND/EBITDA-
BETA-0.40
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on AKRO?
- LOPJLB’s latest quantitative signal on Akero Therapeutics, Inc. (AKRO) is BUY in a BULL regime. Signals are updated daily.
- What market regime is AKRO in?
- Akero Therapeutics, Inc. (AKRO) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Akero Therapeutics, Inc. (AKRO) do?
- Akero Therapeutics, Inc. is a biopharmaceutical firm dedicated to addressing cardio-metabolic disorders, with a specific focus on nonalcoholic steatohepatitis (NASH). Its primary objective is the creation of therapeutic agents aimed at re-establishing metabolic equilibrium and enhancing overall well-being. The company's flagship investigational drug is efruxifermin (EFX), a synthetic analog of …